Trial intelligence / Profile preview

Peritoneal nebulized ropivacaine dose comparison for pain control after laparoscopic cholecystectomy

2009-018247-24Phase 3Active

Sponsor
Fondazione IRCCS San Gerardo dei Tintori
Start
Mar 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (3 arms), sponsored by Fondazione IRCCS San Gerardo dei Tintori. Primary endpoint: Morphine consumption. Started Mar 2010; status: active.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2009-018247-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-018247-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call